|
PIGP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.059900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.508010E-02 |
| Normal-vs-Stage2 |
3.007900E-02 |
| Normal-vs-Stage3 |
3.197600E-01 |
| Normal-vs-Stage4 |
6.500200E-02 |
| Stage1-vs-Stage2 |
7.080200E-01 |
| Stage1-vs-Stage3 |
5.070600E-01 |
| Stage1-vs-Stage4 |
7.854200E-01 |
| Stage2-vs-Stage3 |
4.323800E-01 |
| Stage2-vs-Stage4 |
9.948000E-01 |
| Stage3-vs-Stage4 |
5.390400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.117200E-03 |
| Normal-vs-AfricanAmerican |
9.808500E-02 |
| Normal-vs-Asian |
6.993000E-01 |
| Caucasian-vs-AfricanAmerican |
4.403400E-01 |
| Caucasian-vs-Asian |
5.143600E-01 |
| AfricanAmerican-vs-Asian |
6.708000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.052000E-02 |
| Normal-vs-Female |
1.192630E-01 |
| Male-vs-Female |
3.790800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.721000E-01 |
| Normal-vs-Extreme_Weight |
6.204600E-03 |
| Normal-vs-Obese |
7.395500E-02 |
| Normal-vs-Extreme_Obese |
1.012590E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.296000E-01 |
| Normal_Weight-vs-Obese |
7.916600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.854200E-01 |
| Extreme_Weight-vs-Obese |
3.492800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.412000E-01 |
| Obese-vs-Extreme_Obese |
7.114200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.290200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.280100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.208460E-02 |
| Normal-vs-Age(81-100Yrs) |
1.795850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.973800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.767200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.433400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.216800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.783600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.483550E-02 |
| Normal-VS-Type2 PRCC |
9.888200E-02 |
| Normal-VS-KIRP CIMP |
3.491800E-01 |
| Normal-VS-Unclassified PRCC |
3.963900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.610200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.473600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.778400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.827000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.744200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.240030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.478200E-02 |
| Normal-vs-N1 |
8.028800E-01 |
| Normal-vs-N2 |
4.546500E-02 |
| N0-vs-N1 |
2.682600E-01 |
| N0-vs-N2 |
4.332600E-01 |
| N1-vs-N2 |
3.077600E-01 |
|
|
